IBEC is bioprinting partner in major 3D printing hub in Catalonia Blog Post

The Institute for Bioengineering of Catalonia (IBEC), based at Barcelona Science Park, is to be part of a the Global 3D Printing Hub, a 3D printing infrastructure in Catalonia, which will receive up to 28 million euros from the Generalitat by 2020 to consolidate Catalonia as a world leader in 3D printing, one of the key technologies in industry 4.0. The Global 3D Printing Hub will be headquartered in 10.000m2 of the Campus Diagonal Besòs in Barcelona.


A genome-editing strategy to study cancer stem cells in human tumours Blog Post

In EMBO Molecular Medicine, IRB Barcelona scientists at PCB report a technique based on a combination of CRISPR/Cas9 genome editing and patient-derived tumour organoids that allows the study of cell heterogeneity in human tumours.The novel approach was used to examine the behaviour of colorectal cancer stem cells by tracing specific marker genes.


Experience the leading science with its main actors! Blog Post

Getting society closer to science, creating scientific vocation and making interaction easier between the audience and scientists are the main goals of the 15th edition of the Live Research Fair, which will take place in CosmoCaixa Barcelona from the 3rd to the 6th of May. The event is co-organized by the Barcelona Science Park (PCB) and the Obra Social “la Caixa”, with the support from the Barcelona City Council and the Spanish Foundation for Science and Technology (FECYT).


IRB Barcelona opens brand new laboratory for analysis of genomic ‘big data’ Blog Post

Researcher in the field of bioinformatics and genomics Fran Supek is starting his Genome Data Science (aGENDAS) laboratory at the  Institute for Research in Biomedicine (IRB Barcelona), within the Structural and Computational Biology Research Programme. The recruitment of Supek is a clear demonstration of IRB Barcelona’s commitment to offering leadership opportunities to young investigators and to recruiting highly promising scientific talent at its headquarters at the Barcelona Science Park.


Baula has been seclected to become part of the FuTUR Impact program of Ship2B Blog Post

Clean & Health & Eco Baula has been one of the two companies selected to become part of the  FuTUR Impact program, the investment and acceleration platform for high social impact startups in the sector of tourism of the Ship2B Foundation. The company, based at the Barcelona Science Park, has developed an innovative and patented formula worldwide to manufacture and distribute any cleaning product, in the form of individual tablets and easy dissolution, 100% sustainable and responsible to the environment. 


BIST awards the first five Ignite multidisciplinary projects Blog Post

In the framework of the BIST Founding Conference –held last Friday at the Center for Contemporary Culture of Barcelona– the Barcelona Institute of Science and Technology (BIST) –located at the Barcelona Science Park– announced the five winning proposals for the 1st BIST Ignite call. The program takes place in two phases: in the first, the selected projects will receive 20,000€ each. By the end of 2017, the two projects with the highest potential will be selected to receive additional funding of 50,000€.


Transgenic plants against malaria Blog Post

An international research team led by researchers from the Centre for Research in Agricultural Genomics (CRAG) and the spin-out Sequentia Biotech based at the Barcelona Science Park has been able to obtain, through genetic engineering, Artemisia annua plants that produce twice as much artemisinin molecule, the main component of malaria treatments worldwide. This finding could be a major step towards reducing the production costs of antimalarial drugs.


Dr Thomas Högberg to head up Mind the Byte office in Scandinavia Blog Post

Mind the Byte, located at the Barcelona Science Park, continues to reinforce its international presence. To this end, Thomas Högberg is joining the company as Business Development Director Scandinavia and Senior Advisor in order to consolidate computational design services in one of the most important pharmaceutical and biotechnology markets in Europe. He will carry out these responsibilities from the company’s offices at the Copenhagen Bio Science Park (COBIS).


Pangea Oncology, the first laboratory accredited in Spain to perform liquid biopsy for cancer treatment Blog Post

Pangaea Oncology –located at the Dexeus University Hospital and associated company of PCB – has been the first laboratory to be accredited in Spain for the determination of oncological biomarkers in blood (liquid biopsy) by the norm UNE-EN ISO 15189. This laboratory has great experience in the field of oncology, and was the first to be accredite in 2009 for the analysis in tissue of mutations in genes related to tumor processes, specifically in lung cancer. The result of these analyzes allows to predict the response to certain drugs and to apply personalized medicine to patients.


How tumor cells hijack healthy cells to promote metastasis Blog Post

A team of researchers led by Xavier Trepat –ICREA research professor at the Institute for Bioengineering of Catalonia (IBEC) based at PCB– has identified a mechanism by which cancer cells manage to escape the tumor to promote metastasis. The study, which was published today and will be on the cover of the prestigious journal Nature Cell Biology (doi:10.1038/ncb3478), and has been supported by the Obra Social “la Caixa”, revealed that tumor cells can reprogramme their healthy neighbours, dragging them out of the tumor and into other tissues.